Compare GNRC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNRC | BIO |
|---|---|---|
| Founded | 1959 | 1952 |
| Country | United States | United States |
| Employees | 9400 | 7450 |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 8.0B |
| IPO Year | N/A | N/A |
| Metric | GNRC | BIO |
|---|---|---|
| Price | $195.60 | $331.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 4 |
| Target Price | $211.75 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 882.6K | 273.2K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.36 | $2.74 |
| Revenue Next Year | $12.51 | $3.20 |
| P/E Ratio | $84.89 | ★ $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $134.80 | $236.73 |
| 52 Week High | $296.44 | $343.12 |
| Indicator | GNRC | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 27.11 | 72.74 |
| Support Level | $183.83 | $296.46 |
| Resistance Level | $198.76 | $343.12 |
| Average True Range (ATR) | 8.96 | 8.95 |
| MACD | -2.85 | 2.73 |
| Stochastic Oscillator | 12.42 | 92.84 |
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.